Joincare Pharmaceutical Group Industry Co Ltd Financial Flexibility Index
Joincare Pharmaceutical Group Industry Co Ltd financial flexibility index. Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of CN¥1.25 Billion (operating CF CN¥1.09 Billion minus capex CN¥155.85 Million) represents 0% of total liabilities (CN¥11.93 Billion). See 600380 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
Financial flexibility index of Joincare Pharmaceutical Group Industry Co Ltd from 1999 to 2025. Historical Financial Flexibility Index trend for Joincare Pharmaceutical Group Industry Co Ltd across 27 annual periods. Check earnings quality score of Joincare Pharmaceutical Group Industry C to evaluate the quality of earnings relative to operating cash generation.
Joincare Pharmaceutical Group Industry Co Ltd Financial Flexibility Index by Year (1999–2025)
Joincare Pharmaceutical Group Industry Co Ltd financial flexibility index by year from 1999 to 2025. Year-by-year free cash flow to debt coverage for Joincare Pharmaceutical Group Industry Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Joincare Pharmaceutical Group Industry C.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CN¥4.66 Billion | CN¥3.89 Billion | CN¥11.05 Billion | ▲ +12.6% |
| 2024 | 0.37x | CN¥4.62 Billion | CN¥3.64 Billion | CN¥12.32 Billion | ▲ +1.6% |
| 2023 | 0.37x | CN¥5.06 Billion | CN¥3.93 Billion | CN¥13.72 Billion | ▼ -1.4% |
| 2022 | 0.37x | CN¥5.13 Billion | CN¥3.98 Billion | CN¥13.71 Billion | ▼ 0.0% |
| 2021 | 0.37x | CN¥4.08 Billion | CN¥2.56 Billion | CN¥10.92 Billion | ▼ -13.5% |
| 2020 | 0.43x | CN¥3.86 Billion | CN¥3.02 Billion | CN¥8.92 Billion | ▲ +15.4% |
| 2019 | 0.37x | CN¥3.02 Billion | CN¥2.31 Billion | CN¥8.05 Billion | ▲ +31.2% |
| 2018 | 0.29x | CN¥2.48 Billion | CN¥1.83 Billion | CN¥8.69 Billion | ▲ +4.4% |
| 2017 | 0.27x | CN¥2.35 Billion | CN¥1.87 Billion | CN¥8.59 Billion | ▼ -14.1% |
| 2016 | 0.32x | CN¥2.14 Billion | CN¥1.64 Billion | CN¥6.74 Billion | ▲ +11.1% |
| 2015 | 0.29x | CN¥1.86 Billion | CN¥1.26 Billion | CN¥6.49 Billion | ▼ -11.6% |
| 2014 | 0.32x | CN¥1.80 Billion | CN¥979.46 Million | CN¥5.54 Billion | ▼ -5.5% |
| 2013 | 0.34x | CN¥1.62 Billion | CN¥635.52 Million | CN¥4.72 Billion | ▼ -10.6% |
| 2012 | 0.38x | CN¥1.60 Billion | CN¥734.36 Million | CN¥4.16 Billion | ▲ +18.1% |
| 2011 | 0.33x | CN¥1.09 Billion | CN¥650.36 Million | CN¥3.35 Billion | ▼ -65.6% |
| 2010 | 0.94x | CN¥1.69 Billion | CN¥1.11 Billion | CN¥1.79 Billion | ▲ +80.4% |
| 2009 | 0.52x | CN¥912.53 Million | CN¥605.66 Million | CN¥1.74 Billion | ▲ +52.4% |
| 2008 | 0.34x | CN¥672.72 Million | CN¥455.01 Million | CN¥1.96 Billion | ▼ -1.3% |
| 2007 | 0.35x | CN¥675.89 Million | CN¥429.26 Million | CN¥1.94 Billion | ▼ -15.0% |
| 2006 | 0.41x | CN¥762.69 Million | CN¥272.50 Million | CN¥1.86 Billion | ▼ -23.6% |
| 2005 | 0.54x | CN¥730.86 Million | CN¥363.13 Million | CN¥1.36 Billion | ▲ +67.3% |
| 2004 | 0.32x | CN¥461.61 Million | CN¥241.71 Million | CN¥1.44 Billion | ▲ +56.7% |
| 2003 | 0.20x | CN¥282.85 Million | CN¥172.25 Million | CN¥1.38 Billion | ▼ -68.1% |
| 2002 | 0.64x | CN¥328.22 Million | CN¥236.13 Million | CN¥511.40 Million | ▼ -24.3% |
| 2001 | 0.85x | CN¥293.34 Million | CN¥223.79 Million | CN¥346.20 Million | ▲ +76.4% |
| 2000 | 0.48x | CN¥241.07 Million | CN¥171.61 Million | CN¥501.77 Million | ▲ +48.7% |
| 1999 | 0.32x | CN¥158.97 Million | CN¥109.82 Million | CN¥492.14 Million | — |